{"name":"Arrow Therapeutics","slug":"arrow-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQLWlpb1BFdEZrMW1WYUxrV3lTX0Z3WDBZc0FHOUwxejEzeFl0dWpnZElpNzl1Z0RpcGJ4R3R3OFdoYWRuc255SnhhNkNTVTUwTDJmaF94aVFYUDlBX1NGcGZFOUhldVNuMEdiVVI4VkJfNkZ0NGp4ZTBldTVOTnViTGxDRHNCeVdaVGpjT1AzcTAxaVY1TzYteVp1RVZ2YXk5bWR6SXBTZDFkUQ?oc=5","date":"2026-03-06","type":"pipeline","source":"BioSpace","summary":"Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar - BioSpace","headline":"Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQQ1pUUTlmX0dOc053UklKdGNoTnpkd1YtRjRyNlpKVjZxQ0xEUmNsbVBxcjVhWDBhVkNscnFycFpVZ3lzZWxFb3VfNzhJdFhkUlhRem5JbFI2b1NHUThhOGU2Mld2TWZ5U0tIYU01UmxCdk9vaklsVFhMZUppRXU4blZqa0NvWjVQZENwbg?oc=5","date":"2026-02-23","type":"deal","source":"Fierce Biotech","summary":"Angelini nocks an AI arrow with $120M Quiver Bioscience deal - Fierce Biotech","headline":"Angelini nocks an AI arrow with $120M Quiver Bioscience deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQblhoZzNOdEh6cVRiTFlPVzg2eGRFRXpoQ3VTVEFuVmVhcFBucHZXN3Voak50c1F3MUpkTlRRcUJBYjhHQ0NTY3I2NTZtSnVmZzhrc3M0V0xXbFQ2cnd0WXotaFg5bmVBRm9vdUhXVlo0ZUhMWElKX2JzWEZ0SnlFTGZScmtfSkxpaVBZUg?oc=5","date":"2026-01-08","type":"pipeline","source":"BioSpace","summary":"Biopharmas Axed 47% More Employees Year Over Year - BioSpace","headline":"Biopharmas Axed 47% More Employees Year Over Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQeU43Y0pramYxTGViLWkwRjl1akhKMUMwV3ZsTzQxeXJneTVmSDNiUlJZWUtoRTRBMzhFNWltMm5NOUZZV3dKS05TRlRWUjk3R09rbFVTTW9fb2FtQ3lBS0dYSkh4Z195bjlMSnBEcEFtTk8tWGJPaDFpREpFRkJOLVp2UUszRFM4cHFHYnNlbzdXN0llVHhrcTZFY1ZpeE03bk51ZQ?oc=5","date":"2026-01-02","type":"earnings","source":"BioSpace","summary":"Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4 - BioSpace","headline":"Big Pharma Dealmakers Joined by Spunky Group of Biotech Buyers in Q4","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPX3lxQUlJaUhadlROQlZNUnN6T19feUN2VVR4cVlFc01CVE9FVG82QXRjcTg2SlNiLVA3ZkhDeHBhQ1FLdnZrQWxwUEQya2VjcHlBZjZEX0NlckhaU1B0ODdpRFVZaXRwTi05MlJuLVl5WHJNY3pjUlJDazZISWVxYmFiR2hVSXlobnlRQm5maGNzQkhtNzl2V3ZYXzBlYmNrMkwtcmJoeVhVaDhOU1RGbktNUEVyVGh4VkNOaWFBcw?oc=5","date":"2025-12-01","type":"regulatory","source":"BioSpace","summary":"As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation? - BioSpace","headline":"As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNd05UdnRDMU9hQVBDdWhWSUJRcDVEMmtjdU5YS1hKRGNhM3h6WlhlaU1qaGFYWUtnMkV3cTlpSmk4MloyU2I1WlV3a3dCUWxBcEpaWk1rdXhXZ3pSN3lrZy0wV2pUOEwtM0NSdXM2MTVkMG1nM29nVXo5a1NwdktQREtaQ0N5SW5JODhiX2VjYmg1QURSWmhYQlpxNnBTc1lwWGg2RXZJRVlQcFJYczM2cDhhMEZZNTlheWF5V1hB?oc=5","date":"2025-11-18","type":"regulatory","source":"fiercepharma.com","summary":"Arrowhead strikes true with 1st FDA approval, but Ionis competition looms - fiercepharma.com","headline":"Arrowhead strikes true with 1st FDA approval, but Ionis competition looms","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNT05rLVltSGItU3FXekE2bEZ4SjNtMnRUdVZ2bTRDaW9vTGZXcEhUZlduWWxOeDlKV3IyQjNYMFc2eE9xSURTbDhWQTBOckhzOUN4bWlkY3gybzZReFB2LXFTYWdzUlZJZlpJUm1YeWc3dU5NWnZwRXN4RXBWTWZFNkNYdVlseW01a3ZTV245OU1jMzhrY3NkWkktQm9RQW9IeWo0dk16amsxNGNfYTlVSTY5eHNRM3ZfaUUtSg?oc=5","date":"2025-11-11","type":"deal","source":"fiercepharma.com","summary":"With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health - fiercepharma.com","headline":"With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMC13TzRxa2ROd3Q0anFBLWZONTRTSWJHWFNuSEFzRTZjSHU5QmZYbW56ODRSYXVFc3huY0pudVFtaHNVNGIxdm5acVRBYzM4NEw5Qnl4N3QtQzFLZTBxSmxsWUd0TnJWSTBtRjlsMDJBdDNIR1ZZSmtNeVBxWk1XTFVXX2JhYm1QR3F4ekdRaWd1YkRmN0FEWlN4alUwa3JaWTFaTWt5clBWRkRYMV9PRFJVRWl0c01ZSGtIbg?oc=5","date":"2025-10-21","type":"trial","source":"Fierce Biotech","summary":"Neuphoria nixes social anxiety program and starts strategic review after phase 3 flop - Fierce Biotech","headline":"Neuphoria nixes social anxiety program and starts strategic review after phase 3 flop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQeTFwbXZxTGxTRTktTGJRVzZ6LTBHdFhkWWczVDMyR1dyLXhSVzFkMXZacml6RDhkQ1Nuejl2NlJtWGVocy1oT2JZYUpydE5UMFgyakFwdE1uUzRZbklaMDQydzJsQ1l3dEE1NXppNTZzTk9iZmpqeTg2bk5BUHBlYXlsREp1YnhXWnFsZHA3ZEdrYUpLU1EtcW5mSjAzaXpqMkJ6anh2a180M3hCYmlNMlJBWQ?oc=5","date":"2025-10-06","type":"pipeline","source":"fiercepharma.com","summary":"Myeloid Therapeutics creates new identity after pipeline outgrows its name - fiercepharma.com","headline":"Myeloid Therapeutics creates new identity after pipeline outgrows its name","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPcGliRnJVcWFhVVp4ejYxLU9sT01haU5oS01tRjRDZDFKYjhOMlI2U29pVHppVS1WTHRBVjUyTDE3Vk9oWFpvTGd0RWlfdC04dkV5dVN0Rmg0M3phbWd0YVVMb2ktcTA3a1doNWpNOWktTWlNV2pQVDJ5Y0puNUEwNEZMVVdmZVJDMUdmRUFDSndocWFRYWpWczZyWktIR2JmRlE?oc=5","date":"2025-09-02","type":"deal","source":"Fierce Biotech","summary":"Novartis takes another shot at alpha-synuclein with $2.2B Arrowhead CNS deal - Fierce Biotech","headline":"Novartis takes another shot at alpha-synuclein with $2.2B Arrowhead CNS deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWmN1RzRGVWVBVEdOWFN3ak1UTHoyMTYtNFJReFZEQ3dCU1JmOUVVRUlWMWE0bS12RmVxVzFDc01hZGJtb3lJOGRzTUlzblI5YWtaVGhMdnF1WHdsS0x4S3VkMGhkd0tGcDlaZDhGaVRiZGtBOFJHSVR6QWc5ZUFTaldkMG1fN1RzSjJVOVhJOFhCYThJMEpfOVNLcUtCSjJ4cDllb1JNQWxSYU11cFA0OWEtQWlnMkZ5R29DWDRtakpfRFVsY0pB?oc=5","date":"2025-02-10","type":"deal","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics - Ar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQMk9fLUJ5NlBQRzUwTDdtX0ZseklTekExMV9qN2s4TUFvNFh6NUphRnNCem9sSW5xS1p0SlFSaXdHRWdzajRCS3RvTmxwSnAyMVpFUFI3Sm0yb3F1cW5reG8yLUJSX1JsMUhsZHBoTUw4a1NzelJKOUFGb1NyX2Z1NnU0TkF6cFZDLVRXZjV6R1BWRFQwN1ZPNVQ1cFg1SnIxakdlMXJTR0dxWlE0ZkVrVExNM3RPbVhUQjl6a1g1RFdaamh1MUE?oc=5","date":"2024-03-19","type":"deal","source":"BioWorld News","summary":"Aska Pharmaceutical partners with Red Arrow Therapeutics on new preeclampsia treatment - BioWorld News","headline":"Aska Pharmaceutical partners with Red Arrow Therapeutics on new preeclampsia treatment","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}